Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update
Go back to Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 79.80 +0.09 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.71 | 52 Week High | $10.00 | |||
| Open | $80.03 | 52 Week Low | $3.22 | |||
| Day High | $82.31 | P/E | N/A | |||
| Day Low | $79.22 | EPS | $-0.46 | |||
| Volume | 715,875 | |||||
